Mental and Behavioral Dysfunction in Movement Disorders
Humana Press Inc. (Verlag)
978-1-58829-119-6 (ISBN)
1 Historical Issues in the Study of Behavioral Dysfunction in Movement Disorders.- 2 Fundamental and Clinical Evidence for Basal Ganglia Influences on Cognition.- 3 Integrating Cognition and Motivation into the Basal Ganglia Pathways of Action.- 4 Understanding Corticobasal Ganglia Networks as Part of a Habit Formation System.- 5 The Role of the Cerebellum in Cognition and Emotion.- 6 Assessing Cognition in Movement Disorders.- 7 Disorders of Intention in Parkinsonian Syndromes.- 8 Cognitive Control in Frontostriatal Disorders.- 9 Disorders of Speech and Language in Parkinson’s Disease.- 10 Distinctive Features of Apraxia in Corticobasal Degeneration and Other Neurological Illnesses.- 11 Neuropsychological Deficits in Cerebellar Syndromes.- 12 Induction and Reversal of Cognitive Deficits in a Primate Model of Huntington’s Disease.- 13 Induction and Reversal of Cognitive Deficits in a Primate Model of Parkinson’s Disease.- 14 Catecholamines and Cognition: Bridging the Gap Between Animal Studies and Clinical Syndromes.- 15 Nondopaminergic Influences on Cognition in Parkinson’s Disease.- 16 Cognitive Consequences of Neurosurgery for Parkinson’s Disease.- 17 The Clinical Spectrum of Dementia in Movement Disorders: An Overview.- 18 Neuropathological Distinctions and Similarities in Movement Disorders with Dementia.- 19 Homologies Between the Genetic Etiology and Pathogenesis of the Synucleinopathies and Tauopathies.- 20 Prevalence, Incidence, and Risk Factors for Dementia in Parkinson’s Disease.- 21 Neuropsychiatric Co-Morbidity in Dementia With and Without Movement Disorders.- 22 Neurotransmitter Correlates of Neuropsychiatric Symptoms in Dementia with Lewy Bodies.- 23 Acetylcholinesterase Inhibitors in the Treatment of Dementia in Parkinson’s Disease.- 24Mood Disorders and the Globus Pallidus.- 25 Cortical-Limbic-Striatal Dysfunction in Depression: Converging Findings in Basal Ganglia Diseases and Primary Affective Disorders.- 26 Agitation and Apathy in Hyper- and Hypokinetic Movement Disorders.- 27 Diagnosis and Treatment of Depression in Parkinson’s Disease.- 28 Diagnosis and Treatment of Hallucinations and Delusions in Parkinson’s Disease.- 29 REM Sleep Behavior Disorder in Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy.- 30 Psychogenic Parkinsonism and Dystonia.- 31 Clinical Management of Psychosis and Mood Disorders in Huntington’s Disease.- 32 Clinical Management of Aggression and Frontal Symptoms in Huntington’s Disease.- 33 Heterogeneous Psychopathology of Tourette Syndrome.- 34 In Search of the Pathophysiology of Tourette Syndrome.- 35 Obsessive—Compulsive Disorder as a Frontostriatal-Thalamic Dysfunction.- 36 Dyskinesia in Patients with Schizophrenia Never Treated with Antipsychotics: Conceptual and Pathophysiological Implications.- 37 Medical and Psychosocial Determinants of Quality of Life in Parkinson’s Disease.- 38 Sexuality and Parkinson’s Disease.- 39 Daytime Sleepiness and Sleep Attacks in Idiopathic Parkinson’s Disease.- 40 Natural Evolution and Life Expectancy in Parkinson’s Disease.
Erscheint lt. Verlag | 27.3.2003 |
---|---|
Zusatzinfo | XV, 561 p. |
Verlagsort | Totowa, NJ |
Sprache | englisch |
Maße | 178 x 254 mm |
Themenwelt | Medizinische Fachgebiete ► Chirurgie ► Neurochirurgie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
ISBN-10 | 1-58829-119-7 / 1588291197 |
ISBN-13 | 978-1-58829-119-6 / 9781588291196 |
Zustand | Neuware |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich